Goldman Sachs is speaking very highly about this high-quality stock. The post Why this ASX 200 stock could be one of the best ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ResMed has grown into a company that specialises in non-invasive technology solutions that improve sleep health worldwide.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

ResMed’s EPS and revenue exceeded forecasts for Q2 FY2025. Stock price declined 6.6% in after-hours trading despite strong earnings. ResMed launched new products and expanded its digital health ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered ...

That was up 10% year over year, driven by growing demand for its sleep devices and masks and growth in its Residential Care Software business. ResMed also achieved a 52% increase in income from ...

Our midcycle 35% EBIT margin forecast is broadly unchanged. We forecast slight margin expansion as ResMed’s sales mix shifts to higher-margin masks, and the cost inefficiency of simultaneously ...

with device revenues beating consensus and masks coming in line. The share price clearly anticipated more of an upgrade which wasn't forthcoming, Jarden points out, considering the gross margin ...

Led by growth in the U.S., ResMed’s first half achieved 12 per cent revenue growth over the same period last year, with devices and masks both growing by 11 per cent in constant currency terms during ...